Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli
- 18 October 2007
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 27 (1) , 85-88
- https://doi.org/10.1007/s10096-007-0401-6
Abstract
This study was conducted to evaluate the epidemiology and clinical features of bloodstream infections caused by extended-spectrum β-lactamase-producing E. coli (ESBL-EC) in community-onset bacteremia. Of 929 episodes of community-onset E. coli bacteremia, 4.1% (38/929) had bacteremia with ESBL producers. Of these, 63.2% (24/38) were further classified as healthcare-associated infections. Although most patients had risk factors for infection due to ESBL producers, three patients with urinary tract infection, four patients with cholangitis, and one patient with a liver abscess had no identified predisposing risk factors. The 30-day mortality was 21.1% (8/38). ESBL-EC is a significant cause of bloodstream infection, even in patients with community-onset infection.Keywords
This publication has 12 references indexed in Scilit:
- Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical ChallengeClinical Infectious Diseases, 2006
- Extended-Spectrum β-Lactamases: a Clinical UpdateClinical Microbiology Reviews, 2005
- Bloodstream Infections Due to Extended-Spectrum β - Lactamase-Producing Escherichia coli and Klebsiella pneumoniae : Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial TherapyAntimicrobial Agents and Chemotherapy, 2004
- Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized PatientsJournal of Clinical Microbiology, 2004
- Community Transmission of Extended-Spectrum ß-LactamaseEmerging Infectious Diseases, 2003
- Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology LaboratoryJournal of Clinical Microbiology, 2001
- The Changing Epidemiology of Staphylococcus aureus?Emerging Infectious Diseases, 2001
- New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniaeThe American Journal of Medicine, 1999
- Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemiaJournal of Antimicrobial Chemotherapy, 1999